{"name":"Eikon Therapeutics","slug":"eikon-therapeutics","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMifEFVX3lxTFBOaWVUTlVhcmdFcmctSGdsekp5SVVfblVxd2JRZXRfREdXakxPZEFWeFBJTm5NM0d6YjFPTTNwdG9MVkVGeS1tYlh2aWJvS2duODNkREtPajhtS1MtNUsybWZqNjFfVXUxZ2ZYVzNEZGlzQUVpMVgzYXZqbnU?oc=5","date":"2026-02-06","type":"pipeline","source":"statnews.com","summary":"A sign biotech is back? Four drugmakers go public, raising nearly $1 billion in all - statnews.com","headline":"A sign biotech is back? Four drugmakers go public, raising nearly $1 billion in all","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiU0FVX3lxTFBnWTh0eTc3Q1lkazZlWndRVDY1R0ZVRU1fMHpJbmFPcDhIZXBVS3h5LTEyN09XMVdsUFBEcjBGaFBsWkJHWG1ESUhZeF82azVuTEdR?oc=5","date":"2026-02-05","type":"pipeline","source":"FirstWord Pharma","summary":"Updated: Eikon prices $381M IPO, but shares tumble in market debut - FirstWord Pharma","headline":"Updated: Eikon prices $381M IPO, but shares tumble in market debut","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipgFBVV95cUxPVGEyVnBISmFjd0M2MjlkTFhqZTdMdVhlbDZSMU9tTnlObkg5QXVtY0ttOGVaZU1ja0ZKOU1tNF8xRUVzY3lYUHpsOG9kRTdBM1RaR2V1OTh4dGxka2NJMlBvQUZ6SEp0dEhlalNaZnlUaUlqQmI2UFotR0JqdllGZHk3azVPWks1cWxsWWo5NWJ1cGpzbjg4dk82Rl95RHJQSUtsQzZR?oc=5","date":"2026-02-05","type":"pipeline","source":"Fierce Biotech","summary":"Eikon's upsized $381M Nasdaq listing marks largest biotech IPO since 2024 - Fierce Biotech","headline":"Eikon's upsized $381M Nasdaq listing marks largest biotech IPO since 2024","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMipAFBVV95cUxNVmd5ZGoxTzZMa0hzLW1tczdxU2xpUnJnY05adUs1ajZZSzAzcndMZ3hGU1doVHpvWC10dko3bEJCMUhoajVQNjEtdGg3ai1UN3VhR3NFd3p6akJGVWFla25nNUZraXV3aUlTLWhTcE5WME4yZG1BS1BqWFlwc2tmTDFJUURDMnVYSm5Da0JDUEQ3U0ZwcGxrS2toeW5QMEJDV0dTeQ?oc=5","date":"2026-02-05","type":"trial","source":"MedCity News","summary":"Eikon Therapeutics Continues the IPO Parade, Raising $381M for Cancer Drug Clinical Trials - MedCity News","headline":"Eikon Therapeutics Continues the IPO Parade, Raising $381M for Cancer Drug Clinical Trials","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMizAFBVV95cUxNUndOYWtKRm8wc050VkR2OXlLYUlEMDlKLXYwR2piTkdrb1J0eXVDRGgtV0ZHcGh5LUNMVFZXYVkzWW9rd1VXNnRmMmlsdmViem1wQkdlcWYwMzBxX0Vxdm9pQ0Vrb05wNWVlYXdOU1dSMFZrMmNwN3U3c1J3OWI1NnpwVnYxU2E2dVdSNTMxdTF2UHNPZmlkN2xRdVUyOUxXemVnZFVDcC1MZERjUzJ4M04zbWxVcERaMDRMWUV3bXgwb1BSUU5ycGdkd2Y?oc=5","date":"2026-02-04","type":"pipeline","source":"Reuters","summary":"Perlmutter-backed Eikon Therapeutics raises $381.2 million in IPO - Reuters","headline":"Perlmutter-backed Eikon Therapeutics raises $381.2 million in IPO","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijAFBVV95cUxQNkJvN19kcmtOZWtGcnktRVM5cWRmQjg5RmxtYUJHYjVTVDljQnZlRXlndE1LQkhXUEx1X1pxNW1Sa1pZZ2ZmV0RhWFFFOElIMEVycTNBQWJrMkVyMWE0NDBVdnByWWF1aWFZcUxMTW9acDZPMmNkMFl3Qk5mbEw3b2VsaW50dHZUUGc3bA?oc=5","date":"2026-02-04","type":"pipeline","source":"BioPharma Dive","summary":"Eikon Therapeutics nets a $381M IPO amid burst of biotech offerings - BioPharma Dive","headline":"Eikon Therapeutics nets a $381M IPO amid burst of biotech offerings","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiygJBVV95cUxOZlI3QXJKUGRmSC11ejhBQzhiS0g5dk1MNHNiN0tEM0ZSYUpnMnNIWG00VUJONTFuckJsOGhJeENJZXB1eF9rUUpUU1lhb3BFc2ZJTjhlY0hQNFc1T0trZ3RrYmRvWjFmQ1V5d0ZZWGxLNy1oYXhidHRSY1FJd1ZvWVFaWUc1WTlWSFV4b1JHZkVwZFVEWnJieFFHWGtLUDVTUnNuZHFvRklIT1I0YmpwVHFLcnpYNzB0NWNvX3pMZDlxdGcyQl9EM2FHSGVqRkVxYkRSQlFEVDJkVWVQdkFRWXREME04S3cwNGpMSFNCWTZ5bTA1T0NNUDNMOHJtbWlPT3JBMmN2VnZ3S0x5bGlGX2ZyRTdIOGV1S2kxVnFadnBKYUNhZVBHaHo1LVZqbmlyU1JwVm5PSzBTLTE5bUNRY2ZlUEVzaUxNN2c?oc=5","date":"2026-01-30","type":"pipeline","source":"MSN","summary":"Merck reportedly eyeing $30M stake in Eikon Therapeutics’ IPO - MSN","headline":"Merck reportedly eyeing $30M stake in Eikon Therapeutics’ IPO","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijAFBVV95cUxNQ0RWbnB1ekY0MlRjcFcxWGxoeTVkbXV0TjZVa1pOX1JHSm5wRUVud1Nnc3poaDZkaWNXS1ZiN0EzVFJMZlpwMDNWb0E5TWp0ZEdQN0VXUFJxTFJlbzUydTVNLW1PUy1ESXAxcXJQQWhFOVVIUGtaR25UUkRiaWRsNGpMS1A4b1IwekVvQQ?oc=5","date":"2026-01-28","type":"pipeline","source":"Yahoo Finance","summary":"Eikon ‍Therapeutics targets $908 million valuation in US IPO - Yahoo Finance","headline":"Eikon ‍Therapeutics targets $908 million valuation in US IPO","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMieEFVX3lxTE5xQjZjLWRrc1BZOWV2TTA4d21XT3hkYmdTZ3JhcTdkUTlOeXNfQjAtS1VONHdkbVFUckxKM2R2UHFaaC0yZmVJcWE3RlU3SHRoRXd6VnlJd0x4eXhYalJuMFYwMV93Z3ExRnRvdDVFMzNaOVVXcVlKTQ?oc=5","date":"2026-01-28","type":"pipeline","source":"pharmaphorum","summary":"Eikon prices its IPO, seeking to raise $318m - pharmaphorum","headline":"Eikon prices its IPO, seeking to raise $318m","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMixgFBVV95cUxQNk9YWXVvdF92bTRTbDVKX0V1XzlFZTNfeThmNGwzbkRScHZfWnB4UVQ2UWhJbGs2LUdyYlNncndYWTdyc2lEZnVaWWhsTEc4QXlKd0dZcHAwVk53NnNmR08wOEQ0cGpMZll6R25CUW9lWEdpS2dQeF9EOUhaZ295SEVCQVhHZUxQaHdpR3FycWgteWkyUGFZenliTHpnUko5YXFhNDA2QVJidWZHbmZCbFZfaks4TTlkUkllNFpxMVYweVI5Ync?oc=5","date":"2026-01-28","type":"pipeline","source":"Reuters","summary":"Merck veteran Perlmutter-led Eikon ‍Therapeutics eyes $908 million valuation in IPO - Reuters","headline":"Merck veteran Perlmutter-led Eikon ‍Therapeutics eyes $908 million valuation in IPO","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitwFBVV95cUxQWjhzUmpjOF9CVkszUUJ3UGp6X0I2ZjAwWGJMVGc1REt1Z1hWWWJjLWZBLWV3M3prU0MzNU9KT09Pc05WMmJiN3FnRXVZc3lINVRPM2oxbEtJc01rQ3lVSkFENzV0ai1zTTI3TDB6dEE4dUN3elVWX3E1ZkpiOHF5TXVjUktUWHgtN0RyWWRHNnRxdEpoYlBHR0c5REtOZ09PSnU1Z1h5YWxDb2UxTFN1Q3M2MkhWbDQ?oc=5","date":"2026-01-14","type":"pipeline","source":"seekingalpha.com","summary":"Eikon Therapeutics Launches IPO For Ambitious Oncology Pipeline Development (Pending:EIKN) - seekingalpha.com","headline":"Eikon Therapeutics Launches IPO For Ambitious Oncology Pipeline Development (Pending:EIKN)","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMioAFBVV95cUxNb0pnbEF1WldINXlMRklfbXFacUg4Y2c4ZC1id0ZPUE9BeUNMUmNJQTdXMnBRSl8tVVhkSU5CVUZUUHBiQURzTE5BT0Fmdl9ObnZ6dWMtRmktUVpuWFY0TE50Z3BMRDRtS1dyUTFONnZzS1cyVXdrSEcwdGphOWZkUDNFdHhQZk9jUXV5UWUwejRIdjBERU5KZXczekJxcWYt?oc=5","date":"2026-01-12","type":"pipeline","source":"The Pharma Letter","summary":"Aiming to become ‘generational leader’, Eikon goes public - The Pharma Letter","headline":"Aiming to become ‘generational leader’, Eikon goes public","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":2,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}